AstraZeneca Gets A Reprieve But Will Have To Earn Its Independence
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer has walked away from AstraZeneca – for now – but the big pharma can make another offer later this year under U.K. takeover laws. AstraZeneca will need to give investors a reason to believe it deserves to go it alone.